Rare diseases
Investigational molecules
Locations
Skeppsbron 16, Stockholms Domkyrkofors., 111 30 Stockholm, Sweden
Sixera Pharma AB focuses on netherton syndrome, a rare inherited skin disorder characterized by impaired skin barrier function and chronic dermatologic symptoms.
Its clinical research is centered on therapeutic options for patients with severe, long-term cutaneous disease.
Sixera Pharma AB runs clinical trials in conditions such as Netherton's syndrome, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
